Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.43B | 24.67B | 21.55B | 24.59B | 21.52B |
Gross Profit | 5.69B | 4.65B | 3.91B | 5.00B | 3.92B |
EBITDA | 3.49B | 2.52B | 2.00B | 2.93B | 2.15B |
Net Income | 2.31B | 1.55B | 999.00M | 1.97B | 1.33B |
Balance Sheet | |||||
Total Assets | 33.91B | 34.64B | 30.16B | 29.52B | 29.73B |
Cash, Cash Equivalents and Short-Term Investments | 9.89B | 8.36B | 7.63B | 5.57B | 6.44B |
Total Debt | 1.54B | 1.63B | 1.38B | 1.73B | 1.55B |
Total Liabilities | 14.77B | 17.19B | 14.73B | 14.83B | 16.46B |
Stockholders Equity | 19.13B | 17.45B | 15.42B | 14.69B | 13.27B |
Cash Flow | |||||
Free Cash Flow | 2.11B | 774.00M | 2.81B | -363.00M | 1.94B |
Operating Cash Flow | 2.58B | 1.01B | 3.41B | -214.00M | 2.12B |
Investing Cash Flow | -427.00M | -234.00M | -589.00M | -150.00M | -186.00M |
Financing Cash Flow | -612.00M | -79.00M | -770.00M | -518.00M | -260.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥21.03B | 9.06 | 3.99% | 7.14% | 48.60% | ||
74 Outperform | ¥122.12B | 23.13 | 3.82% | 0.68% | -32.97% | ||
74 Outperform | ¥98.79B | 13.75 | 2.30% | 17.01% | 16.10% | ||
73 Outperform | ¥19.72B | 8.08 | 3.76% | 16.52% | 41.05% | ||
72 Outperform | ¥20.96B | 8.26 | 4.83% | -4.51% | -4.46% | ||
66 Neutral | ¥23.68B | 26.24 | 5.78% | 3.00% | -62.93% | ||
58 Neutral | HK$13.96B | 4.77 | -2.71% | 5.86% | 3.74% | -52.98% |